Doncef SB 1000mg/500mg Injection
Marketer
Altruist Pharmacia Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Doncef SB 1000mg/500mg Injection
Cefixime and Sulbactam injection (1000mg/500mg), a dual-action antibiotic, is indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, curbing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial. Complete the full course, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, avoid driving if experiencing drowsiness or dizziness. For optimal recovery, ensure adequate rest, nutritious food, and ample hydration. Your doctor may order tests to monitor the treatment's impact.
Uses of Doncef SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Doncef SB 1000mg/500mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Doncef SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Doncef SB 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Doncef SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Doncef SB 1000mg/500mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by countering bacterial defenses, thereby amplifying its antibiotic effect.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Doncef SB 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Doncef SB (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Doncef SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Doncef SB 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Doncef SB 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Doncef SB 1000mg/500mg, requires careful administration in individuals with significant hepatic impairment. A modified dosage regimen for Doncef SB 1000mg/500mg Injection may be necessary. Physician consultation is advised. Dosage alteration of Doncef SB 1000mg/500mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Doncef SB 1000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Doncef SB 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Doncef SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently